PRA Health Sciences Archives | Be Korea-savvy
PRA Health Sciences, Symphony Health Launch Metys™ National Market Measurement Tool

PRA Health Sciences, Symphony Health Launch Metys™ National Market Measurement Tool

RALEIGH, N.C., Sept. 18 (Korea Bizwire) — PRA Health Sciences (NASDAQ: PRAH) announced today the launch of Symphony Health’s new national market measurement tool – Metys™ (pronounced Met-IS), the only completely integrated, all-in-one market research solution available from a contract research organization (CRO). The first platform of its kind, Metys delivers pharmaceutical market analytics and intelligence [...]

PRA Health Sciences, Inc. Announces Pricing of Secondary Offering and Concurrent Share Repurchase

PRA Health Sciences, Inc. Announces Pricing of Secondary Offering and Concurrent Share Repurchase

RALEIGH, N.C., Sept. 4 (Korea Bizwire) — PRA Health Sciences, Inc. (the “Company”) (NASDAQ: PRAH) today announced the pricing of the previously announced secondary offering of shares of its common stock.  KKR PRA Investors L.P. (the “Selling Stockholder”), has agreed to sell an aggregate of 6,666,684 shares of the Company’s common stock in an underwritten [...]

PRA Health Sciences, Inc. Announces $500 Million Share Repurchase Program

PRA Health Sciences, Inc. Announces $500 Million Share Repurchase Program

RALEIGH, N.C., Sept. 3 (Korea Bizwire) — PRA Health Sciences, Inc. (the “Company”) (NASDAQ: PRAH) today announced that its Board of Directors (the “Board”) has authorized a $500 million share repurchase program, effective immediately.  Under the program, the Company is authorized to repurchase shares of its common stock through open market purchases, privately-negotiated transactions, secondary [...]

PRA Health Sciences, Inc. Announces Secondary Offering and Concurrent Share Repurchase

PRA Health Sciences, Inc. Announces Secondary Offering and Concurrent Share Repurchase

RALEIGH, N.C., Sept. 3 (Korea Bizwire) — PRA Health Sciences, Inc. (the “Company”) (NASDAQ: PRAH) today announced that KKR PRA Investors L.P. (the “Selling Stockholder”), intends to offer for sale in an underwritten secondary offering 6,666,684 shares of common stock of the Company pursuant to the Company’s shelf registration statement filed with the Securities and [...]

PRA Health Sciences Announces Strategic Alliance Between Symphony Health and Close-Up International

PRA Health Sciences Announces Strategic Alliance Between Symphony Health and Close-Up International

RALEIGH, N.C., Aug. 19 (Korea Bizwire) — PRA Health Sciences (NASDAQ: PRAH) announced today that Symphony Health, the company’s data solutions division, has expanded its global data services by entering into a strategic partnership with Close-Up International, a leading Latin American-based provider of medical prescription and sales audits. “The agreement with Close-Up represents a significant milestone [...]

PRA Named International Clinical Research Company of the Year

PRA Named International Clinical Research Company of the Year

RALEIGH, N.C., May 24 (Korea Bizwire) — PRA Health Sciences, Inc. (NASDAQ:PRAH) is pleased to announce it was recognized by PharmaTimes as the International Clinical Research Company of the Year. This is the fifth year in a row that PRA has received this award. “This award celebrates excellence in the clinical research industry and we [...]

PRA Health Sciences Named International Clinical Research Company of the Year

PRA Health Sciences Named International Clinical Research Company of the Year

RALEIGH, N.C., May 22 (Korea Bizwire) — PRA Health Sciences, Inc., (PRA) (NASDAQ:PRAH) is pleased to announce that for the fourth consecutive year it was recognized as the International Clinical Research Company of the Year. PRA received the award at a PharmaTimes ceremony in London. This award follows PRA’s recent recognition as Clinical Research Company [...]

PRA Health Sciences Named International Clinical Research Company of the Year

PRA Health Sciences Named International Clinical Research Company of the Year

RALEIGH, N.C., May 17 (Korea Bizwire) — PRA Health Sciences, Inc., (PRA) (NASDAQ:PRAH) is pleased to announce that for the third consecutive year it was recognized as the Clinical Research Company of the Year. PRA received the award at the PharmaTimes International Clinical Researcher of the Year ceremony in London. This award follows PRA’s recent [...]